Dechert and Villey Girard Grolleaud advised Affluent Medical on the deal.Affluent Medical, a French medtech company specialising in urology and cardiology, executed its IPO on the Euronext…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
